Institute of Isotopes Co., Ltd. Products Technical Support Search Sitemap Contact
INSTITUTE OF ISOTOPES CO., LTD. Triiodothyronine (T3) [I-125] RIA kit (RK-6M5)
COMPANY
About Us
Contact

BUSINESS UNITS
Radiopharmaceutical
Immunoassay
Molecular Biology
Synthesis
Radiation Technique

PRODUCTS
Complete List
New Products
Technical Support

QUOTATION REQUEST

SEARCH
|| Sitemap

*** Magyar ***

Description

The 125I- L-3,5,3'-triiodothyronine (T3) assay system provides the quantitative determination of T3 in human serum. T3 can be assayed in the range of 0-12 nmol/l (0-780 ng/dl) using 100 µl serum samples. Each kit contains materials sufficient for 500 assay tubes, permitting the construction of one standard curve and assay of 242 unknowns and 1 control in duplicate.

Introduction

Among the thyroid hormones produced in the thyroid gland triiodothyronine (T3) is regarded as the most biologically active molecule, produced up to 80% by the deiodination of tetraiodothyronine (T4) in peripheral tissues.

T3 is found in the bloodstream in a major (99.7%) protein-bound, and a minor (0.3%) unbound, fraction. Variations in total thyroid hormone in blood may result from either changes of binding proteins concentrations, or thyroid hormone production.

T3 contributes significantly to the maintenance of the euthyroid state, and the total T3 level has a role in screening for thyroid disease in conjuction with other tests. T3 alone cannot diagnose hypothyroidism, but it may be more sensitive than T4 for hyperthyroidism.

Principle of method

This assay is based on the competition between unlabelled triiodothyronine and a fixed quantity of 125I-labelled triiodothyronine for a limited number of binding sites on T3 specific antibody. Allowing to react a fixed amount of tracer and antibody with different amounts of unlabelled ligand the amount of tracer bound by the antibody will be inversely proportional to the concentration of unlabelled ligand. Upon addition of magnetizable immunosorbent the antigen-antibody complex is bound on solid particles which are then separated by either magnetic sedimentation or centrifugation. Counting the radioactivity of solid phase enables a standard curve to be constructed and samples to be quantitated.

Contents of the kit

1 vial 125I-TRACER
55 ml, containing about < 1300 kBq 125I-T3 in buffer with red dye and 0.1% NaN3
2x6 vials STANDARD
0.5 ml per vial, containing 0, 0.5, 1.5, 3.0, 6.0, 12.0 nmol/l in human serum with 0.1% NaN3
1 bottle ANTISERUM
275 ml, containing anti-T3 IgG in buffer with blue dye and 0.1% thimerosal
2 vials CONTROL SERUM.
Lyophilized human serum with 0.1% NaN3.

The concentration of the serum is specified in the quality certificate enclosed.
1 bottle MAGNETIC IMMUNOSORBENT (MIS).
275 ml, containing paramagnetic particles in buffer with 0.1% NaN3
.
1 pc Quality certificate
1 pc Pack leaflet

Materials, tools and equipment required

Round bottom polystyrene or polypropylene assay tubes, about 12 x 75 mm
Plastic film to cover tubes
Precision pipettes (100, 500 µl)
Vortex mixer
Magnetic separator
Decanting racks
Gamma counter

Recommended tools and equipment

Orbital shaker
Repeating pipettes

Specimen collection and storage

Serum samples can be prepared according to common procedures used routinely in clinical laboratory practice. Samples can be stored at 2-8 °C if the assay is carried out within 24 hours, otherwise aliquots should be prepared and stored deep frozen (-20 °C). Frozen samples should be thawed and thoroughly mixed before assaying. Repeated freezing and thawing should be avoided.

Do not use lipemic, hemolyzed or turbid specimens.

Preparation of reagents, storage

Store the reagents between 2-8 °C after opening. At this temperature each reagent is stable until expiry date. The actual expiry date is given on the package label and in the quality certificate.

Add 500 µl distilled water to the lyophilised control serum. Mix gently with shaking or vortexing (foaming should be avoided).

Ensure that complete dissolution is achieved, and allow the solution to equilibrate at room temperature for at least 20 minutes. Store at 2-8 °C until expiry date.

CAUTION! Equilibrate all reagents and serum samples to room temperature. Mix all reagents and samples thoroughly before use. Avoid excessive foaming.

Assay procedure

(For a quick guide refer to Table 1)

1 Equilibrate reagents and samples to room temperature before use (min. for an hour).
2 Label tubes in duplicate for each standard (0-12 nmol/l), control serum, samples and total count (T).
3 Homogenize all reagents and samples by gentle mixing to avoid foaming.
4 Pipette 100 µl each of standards, control and samples into the properly labelled tubes.
5 Pipette 100 µl of tracer into all tubes.
6 Pipette 500 µl antiserum into all tubes except T.
7 Thoroughly vortex mix all tubes except T for 2-5 seconds. When having an orbital shaker, leave all tubes in the rack holder, fix the holder onto the plate of the shaker, and shake it gently for a few seconds.
8 Incubate the tubes for 2 hours at room temperature.
9 Place T tubes on a separate tube rack. Gently shake and swirl the bottle containing magnetic immunosorbent until homogeneity. Add 500 µl to each tube except T. When using a single pipette, swirl the bottle of MIS after every 15-20 tubes. With the use of a repeating pipette (e.g. Eppendorf), there is no need for repeated homogenisation of MIS reagent.
10 Thoroughly vortex mix all tubes and incubate them 15 minutes at room temperature.
11 Magnetic separation: Attach the rack onto the magnetic separator base and ensure that every tube is in contact with the base plate. Let the MIS particles settle for 5 minutes. Do not remove the rack from separator base after the separation of the solid and liquid phases. Pour off and discard the supernatant. Keeping the separator invert, place the tubes on a pad of absorbent tissue and allow to drain for 5 minutes.
12 Count the radioactivity of all tubes preferably not less than 60 seconds.
13 Calculate the concentrations as described under Calculation of results

Table 1. Assay Protocol, Pipetting Guide (all volumes in microliters)

Total count
(T)

Standard
(S1-S6)

Sample
(M)

Control
(C)

Standard solution 1-6

100

Sample

100

Control

100

Tracer

100

100

100

100

Antiserum

500

500

500

Vortex mix
Incubate for 2 hours at room temperature

Magnetic immunosorbent

500

500

500

Vortex mix
Incubate for 2 hours at room temperature

Place the tubes on the magnetic separator for 5 minutes

Remove the supernatant and blot the tubes on filter paper min. 5 minutes

Count radioactivity (60 sec/tube)

Calculate the results

Calculation of results

The calculation is illustrated using representative data. The assay data collected should be similar to those shown in Table 2.

Calculate the average counts per minute (CPM) for each pair of assay tubes. Calculate the percent B0 / T for zero standard (S1) by using the following equation:

S1 (cpm)
B0 / T % =  ———   x 100
T (cpm)

B0/T% is an optional quality control parameter unnecessary for determination of sample concentrations. Calculate the normalized percent binding for each standard, control and sample respectively by using the following equation:

S2-6 [C, Mx] (cpm)
B / B0 % =  ——————————   x 100
S1 (cpm)

For simplicity, these values are uncorrected for non-specific binding (NSB). This is enabled by low NSB being less than 3% of total count. Using semi-logarithmic graph paper plot B/B0% for each standard versus the corresponding concentration of T3. Figure 1 shows a typical standard curve.

Determine the T3 concentration of the unknown samples by interpolation from the standard curve. Do not extrapolate values beyond the standard curve range. Out of fitting programs applied for computerized data processing logit-log, or spline fittings can be used.

Table 2.    Typical Assay Data

Tubes

Count
cpm

Average
cpm

B0 / T
%

B / B0
%

T

99544
96454

97999

100.0

S1

37085
36434

36760

37.5

100.0

S2

32586
32171

32379

33.0

88.1

S3

25106
24085

24596

25.1

66.9

S4

17947
17736

17842

18.2

48.5

S5

10844
10954

10899

11.1

29.6

S6

7206
6910

7058

7.2

19.2

C

21623
21972

21798

22.2

59.3

Typical standard curve for the T3 I-125 RIA kit
T3 concentration nmol/l

Figure 1.
A typical standard curve
(Do not use to calculate sample values)

Characterization of the assay

Assay parameters

B0 / T 35 ± 5 %
ED-80 3 ± 0.5 nmol/l

Specificity

Cross reactivity values are shown below.

3,5,3’-triodo-L-thyronine (T3)

100%

Thyroxine (T4)

< 0.07%

3’,5’,3,-triodo-L-thyronine (rT3)

< 0.012%

3,3’-diiodo-L-thyronine (3,3’-T2)

< 1.1%

Sensitivity

Better than 0.094 nmol/l, corresponding to the 0-2xSD value.

Precision

5 control samples were assayed in 10 replicates to determine intraassay precision. Values obtained are shown below.

Sample

Mean value
nmol/l

SD
nmol/l

CV
%

1

1.51

0.057

3.8

2

2.11

0.100

4.7

3

2.84

0.074

2.6

4

4.69

0.145

3.1

5

9.08

0.291

3.2

Reproducibility

To determine interassay precision 5 control samples were measured in duplicates in 6 independent assays. Values obtained are shown below.

Sample

Mean value
nmol/l

SD
nmol/l

CV
%

1

1.20

0.018

1.78

2

1.97

0.038

1.94

3

2.98

0.120

4.03

4

4.85

0.207

4.28

5

5.26

0.108

2.06

Recovery

Recovery was defined as the measured increase expressed as per cent of expected increase upon spiking serum samples with known amount of T3. The mean (± SD) recovery % for added T3 (5 samples, 2.5 nM added T3, 2 runs in duplicates) was 106 ± 8.3.

Expected reference values

It is recommended that each laboratory establish its own reference intervals. The expected values presented here are based on testing of apparently healthy blood donors. Samples were measured in duplicates.

In a population (n = 115) of adult female blood donors (ages: mean 36.8 ± 11.5, range 18-61), the mean (± SD) serum concentration of T3 was 2.02 ± 0.6 range (1.14–4.84). As a guide, 1.3–3.4 nmol/l was obtained from normal patients.

In a population (n = 119) of adult male blood donors (ages: mean 39.7 ± 11.9, range 19-64) the mean (± SD) serum concentration of T3 was 1.82 ± 0.3 range (1.24–2.71). As a guide, 1.3–2.4 nmol/l was obtained from normal patients.

For female and male (n = 234, ages: mean 38.3 ± 11.8, range 18-64) the mean (± SD) serum concentration of T3 was 1.92 ± 0.48 range (1.14–4.84). As a guide, 1.3–3.1 nmol/l was obtained from normal patients.

The results obtained should only be interpreted in the context of the overall clinical picture. None of the in vitro diagnostic kits can be used as the one and only proof of any disease or disorder.

Conversion of SI units can be performed according to the following formula:
1 nmol/l = 0.65 ng/ml
1 ng/ml = 1.54 nmol/l

Additional information

Components from various lots or from kits of different manufacturers should not be mixed or interchanged.

Precaution

Radioactivity

This product contains radioactive material. It is the responsibility of the user to ensure that local regulations or code of practice related to the handling of radioactive materials are satisfied.

Biohazard

Human blood products used in the kit have been obtained from healthy human donors. They were tested individually by using approved methods (EIA, enzyme immunoassay), and were found to be negative, for the presence of both Human Immunodeficiency Virus antibody (Anti-HIV-1) and Hepatitis B surface Antigen (HBsAg).

Care should always be taken when handling human specimens to be tested with diagnostic kits. Even if the subject has been tested, no method can offer complete assurance that Hepatitis B Virus, Human Immunodeficiency Virus (HIV-1), or other infectious agents are absent. Human blood samples should therefore be handled as potentially infectious materials.

Chemical hazard

Components contain sodium azide as an antimicrobial agent. Dispose of waste by flushing with copious amount of water to avoid build-up of explosive metallic azides in copper and lead plumbing. The total azide present in each pack is 612 mg.

 

Use by In vitro diagnostic  device Control
Batch code Manufacturer Standard
Caution, consult accompanying documents Radioactive material Magnetic immunosorbent
Biological risk Temperature limitation
Store between 2-8 °C
Tracer
Consult instructions for use Catalogue number Antiserum


Other thyroid function assays
Calcitonin IRMA test RK-83M Free T4 RIA test RK-34CT1
Anti-hTG RIA test RK-8CT
TG IRMA test RK-51CT T4 RIA test RK-11M1
Anti-TPO RIA test RK-36CT T4 RIA test RK-11M5
Turbo TSH IRMA test RK-1M1 T4 RIA test RK-11CT1
Turbo TSH IRMA test RK-1M2 T4 RIA test RK-11CT5
Turbo TSH IRMA test RK-1M5 Free T3 RIA test RK-33CT
Turbo TSH IRMA test RK-1CT1 T3 RIA test RK-6M1
Turbo TSH IRMA test RK-1CT5 T3 RIA test RK-6CT1
Free T4 RIA test RK-34M1 T3 RIA test RK-6CT5
Other immunoassay kits
PRINTABLE VERSION
PDF-FORMAT

Products || Technical Support || Search || Sitemap || Contact || Quotation Request

For business inquiries, please use our Quotation Request form, or check the Contact page.
Your comments about this site (www.izotop.hu) are welcome here: webmaster@izotop.hu